Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Clinical evidence of the benefits of bevacizumab in patients with eye disorders

May 24, 2005

Phase II data support the use of squalamine lactate in AMD

May 23, 2005

Novel integrin inhibitor delivered via sustained-release implant tested for treating eye diseases

May 20, 2005

HDP-P-5F2'DU: A novel intravitreally injectable, crystalline prodrug of 5-flourouracil

May 20, 2005

Alcon presents data on novel VEGFR inhibitors for CNV

May 19, 2005

Linomide analogue Lin-05 demonstrates potent antiangiogenic activity

May 19, 2005

MB-500 promotes corneal wound healing

May 18, 2005

SCR-011, a therapeutic candidate for ocular neovascularization

May 18, 2005

Eye drops with FGLM-NH2 plus IGF-1 reported effective in neurotrophic keratopathy

May 17, 2005

PCL-016 shows promise for adenovirus ocular infections

May 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...